Prepared for the Curie team
People search for the medications Curie already sells hundreds of thousands of times a month. Here's how to turn that demand into paying patients, measured from the first click.
Why we're here
Thank you for the time on our call. You said two things that stuck with us: you're confident Curie can put serious money into ads and have it convert, and you want the funnel tuned before you do. We agree with both, so we spent the time since our call going through Curie the way a new growth lead would on day one.
We went through gocurie.com page by page, walked the start of the weight loss intake, pulled your live ads from the Meta Ad Library, checked what your site loads in the browser, looked at how Curie shows up in search, and read through your Funnel Pages, Landing Page and Paid Media files in Figma.
What we found is a team that can clearly build. You built prescriptions, labs and diagnostics in-house, the product pages cite their trials, and the Figma work shows real angle testing. The gap is not talent. It is that acquisition is not yet a system: most of your paying customers came in through your physicians by hand, and the ads that are running aren't yet tagged to show which ad made a paying patient. What's missing is a growth lead: someone who sets the direction, decides with you what your team builds next for revenue, and runs the channels that bring patients in. That's the seat we would fill.
Below is the audit, then how we'd get the funnel ready to scale, how we'd work with your team, and the plan.
Ryan, Natalie & Ripal, UPRYT
Audit scorecard
Broken
Partial
Working
Before you spend big
Ad money buys reach. Whether that reach turns into paying patients is decided by everything around the ad: what Meta is told counts as a win, which creative earns more budget, what happens after the click, and who is watching every day. You said you want the funnel tuned before you spend big. That is exactly the work.
3 live ads on 2 creatives, both leading with a price anyone can match. Ad links with no UTM tags, so PostHog can't split results by campaign or creative. PostHog shows what happens on your site, but unless paid orders are sent back to Meta, Meta can't learn which ads made paying patients and optimizes for clicks. No Google Search, where "wegovy pill" alone is searched 192K times a month. Spend scales; learning doesn't.
Your checkout comes before the physician visit, which makes a paid order a clean conversion signal with no diagnosis attached. We send that signal to Meta and Google from PostHog with health details stripped out, name and tag every ad, design and test new angles in your Figma every week, and watch the accounts daily so budget moves on early signals.
You said you're confident $10M in ads would convert. Gates are how you get there without paying to find out. The CAC target comes from your margin per order, set together before any money moves.
Paid checkouts reach Meta and Google, health details stripped. Every ad tagged. Until then, spend stays where it is.
GLP-1 angles at a test budget. Budget moves up only when cost per paid checkout holds at or under target on enough orders to trust.
Raise budget in steps of about 20% while CAC holds. Open Google Search on drug-name demand.
Hair loss, new states and prediction care sign-ups, each with its own CAC target.
Your 90-day growth plan, CAC targets and the first priority list for your developers and designers, including the search architecture for weight loss and hair loss.
Paid checkout and approval events from PostHog to Meta and Google, plus a UTM and naming standard.
Built off the offer already converting, with angles from your Figma and new ones we design there.
Test budget running, daily monitoring, a weekly readout in PostHog, and the first priorities shipped by your team.
How we work with you
We work as Curie's embedded growth team, a fractional CMO and CRO. We own the growth plan and answer for the number that matters: paying patients per dollar. We set the direction for your developers and designers, and we do the specialist work ourselves.
The growth strategy, the 90-day plan and the weekly priorities. Together with you, we decide what gets built, tested and funded next, and why.
Clear briefs and specs for your developers and designers, creative direction, and review of what ships. Your team stays focused on the product while every build ties back to revenue.
Tracking and attribution, ad design in your Figma, Meta and Google buying with daily monitoring, experiments on the offer, intake and checkout, lifecycle and search.
A privacy link that opens the terms, homepage stats for a product that hasn't launched yet, ads that can't be told apart by campaign, experiments switched off in PostHog. None of it is hard to fix. It is hard to notice from inside while you are shipping.
Your team
UPRYT
We don't ask for a quarter of patience. The gates mean no new spend runs until tracking is right, and no budget grows until the numbers earn it. You see cost per paid checkout by product, campaign and creative in your own PostHog, and we read it with you every week.
Natalie, on our team, has grown an ad budget from $5K to $250K a month. That is the discipline we bring to yours.
We work as part of your team: in your brand, your ad accounts and your Figma. The accounts, data and creative stay yours.
What you already own
None of this needs rebuilding. It needs pointing in one direction.
A serif and grotesk system, a cream and ink palette, the dot-ring mark and cinematic photography. It already looks like a category leader.
Four FDA-approved GLP-1s and six hair loss treatments, priced, with product pages, shipping and a working intake.
Prediction Care, with a capped first 1,000, "$1,000 of healthcare prediction value, free" and 10 invites per person.
Named physicians, licensed state by state, LegitScript, and trial-cited stats on the drug pages.
PostHog is already installed through a first-party path. Funnels and experiments can run on it tomorrow.
Funnels, landers and ad concepts already designed in Figma, including a careful heart scan (CCTA) copy brief.
The audit
| Area | Finding | Source, checked Nov 6, 2026 |
|---|---|---|
| Live products | Weight loss: Wegovy pill from $149, Foundayo from $149, Wegovy pen from $199, Zepbound KwikPen from $299. Hair loss: 6 treatments from $34 a month. | gocurie.com/weight-loss, /hair-loss, /llms.txt |
| Where Curie treats | California, Illinois, Texas, Florida, New York, Massachusetts. | gocurie.com/coverage |
| Prediction Care | "Coming soon, launching early 2027." Waitlist limited to the first 1,000 people. | gocurie.com, /waitlist |
| Live ads | 3 active Meta ads, 2 creatives, started Oct 14 and Oct 22, 2026; Facebook, Instagram, WhatsApp, Threads and other Meta placements. | Meta Ad Library, search "gocurie.com" |
| Browser tags | PostHog (first-party) and Vercel Analytics present. No Meta Pixel, GA4, GTM or TikTok tag in the browser. No cookie banner seen on the homepage. | Homepage, /weight-loss/wegovy-pill, /visit/wm |
| Manufacturer prices | NovoCare: Wegovy pill $149 (1.5 and 4 mg), pen $199 intro for new patients. LillyDirect: Foundayo from $149. | novocare.com; Lilly launch release (Apr 2026) |
| Search footprint | Domain Rating 6; 2 organic keywords; about 1 visit a month (US). | Ahrefs, Nov 5, 2026 |
| Search demand | "wegovy pill" 192K a month; "foundayo" 86K; "wegovy pill price" 3.5K; "function health" 95K; "superpower health" 4.3K. | Ahrefs Keywords Explorer, US |
| Social | @go.curie on Instagram: 3 posts, 272 followers, links to /weight-loss. | instagram.com/go.curie |
| Site details | Every page checked uses the meta description "Healthcare Reimagined". The sitemap lists 16 URLs but not /coverage or /providers. | Page source; /sitemap.xml |
| Copy errors | Homepage: "that could prevented" and "see what your prediction plan." | gocurie.com |
Where you are today
Someone who finds Curie from an ad, from the homepage and from the waitlist link gets a different product, a different promise and a different price each time.
HOMEPAGE · gocurie.com
1
2
3
LIVE META ADS · Ad Library
1
2
3
WHERE THE ADS LAND · /weight-loss
1
2
THE WAITLIST · /waitlist
1
2
The GTM plan, zero to one
Your model works like $0 trades: free prediction care brings people in, and medications, labs and diagnostics pay for it. Today the free door is a waitlist and most paying customers are onboarded by hand through your physicians. The plan builds both doors to run on their own, so growth no longer depends on physician time, and every ad dollar can be traced to a paid order.
The free front door
Low-cost reach and the reason to choose Curie. Today a waitlist with 10 invites per person; the questionnaire ("Which disease am I most likely to have?") is a natural first step to capture.
Where revenue comes from
Live now: GLP-1s and hair loss in six states, with high-intent search demand. Priced at parity, so prediction care is what makes Curie the one to choose.
"A GLP-1 can change the number on the scale. But what is it changing everywhere else, and what to do next."
Paid Media file, Prediction page. The hair loss page says the same thing: each medication you take affects your overall health into the future. That is the position. It turns a price-parity product into a Curie-only one.
Two loops, measured end to end. Free door: ads and content bring people to prediction care, and each one is shown the care that fits them. Paid door: high-intent ads sell medications directly, and every buyer gets founding access to prediction care. Every step is measured in PostHog.
This is one engine. Every workstream runs every week, not one at a time.
Your Figma files
Across your Funnel Pages, Landing Page and Paid Media files, the design work is ahead of the go-to-market. Here is what stood out.
GLP1 · CCTA · HEALTHCARE CHAT
TESTING
GLP-1 · PREDICTION · CCTA · HAIR LOSS
90-day roadmap
Next steps
Hop on a call with Ryan to talk it through.
